Standout Papers

Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis 2020 2026 2022 2024515
  1. Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis (2020)
    Richard Furie, Brad H. Rovin et al. New England Journal of Medicine

Immediate Impact

57 standout
Sub-graph 1 of 20

Citing Papers

Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
2024 Standout
The interaction of innate immune and adaptive immune system
2024 Standout
16 intermediate papers

Works of Beulah Ji being referenced

Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
2020 Standout
Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
2012
and 2 more

Author Peers

Author Last Decade Papers Cites
Beulah Ji 1238 836 597 30 1.5k
Ana Malvar 1211 711 381 41 1.5k
Damon Bass 1023 717 504 27 1.3k
C Tănăsescu 1257 992 645 40 1.7k
Agneta Zickert 1529 1130 351 52 1.9k
J. D. Reveille 1587 948 276 30 1.9k
Juanita Romero‐Díaz 980 616 258 47 1.2k
Paula Alba 1198 656 269 32 1.4k
H A Austin 1198 588 311 29 1.9k
H Chwalińska-Sadowska 1245 971 254 29 1.8k
Chi Hung To 1501 725 228 45 1.9k

All Works

Loading papers...

Rankless by CCL
2026